Development and persistence of antibody in a high risk institutionalized population given plasma-derived hepatitis B vaccine
- 1 April 1990
- Vol. 8 (2) , 111-114
- https://doi.org/10.1016/0264-410x(90)90132-6
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Effect of anatomic injection site, age and smoking on the immune response to hepatitis B vaccinationVaccine, 1989
- Hepatitis B Vaccine: Persistence of Antibody following ImmunizationInfection Control & Hospital Epidemiology, 1988
- Persistence of specific antibodies after hepatitis B vaccinationJournal of Hepatology, 1988
- Down’s syndrome and hepatitis: an evaluation of carrier statusThe Journal of the American Dental Association, 1987
- Poor seroconversion rate after hepatitis B vaccination in high-risk institutionalized mentally retarded patientsAmerican Journal of Infection Control, 1986
- Long-Term Immunogenicity and Efficacy of Hepatitis B Vaccine in Homosexual MenNew England Journal of Medicine, 1986
- Normal Immune Response to Hepatitis B Vaccine in Patients With Down's SyndromeJAMA, 1985
- Hepatitis B Vaccination in Down’s Syndrome and Other Mentally Retarded PatientsHepatology, 1984
- Summary of worldwide clinical experience with H-B-Vax® (B, MSD)Journal of Infection, 1983
- Immune responses to hepatitis B vaccine in the mentally retardedJournal of Infection, 1983